Connection

GEORGE CHOLANKERIL to Tissue Donors

This is a "connection" page, showing publications GEORGE CHOLANKERIL has written about Tissue Donors.
Connection Strength

1.692
  1. Recent advances in liver transplantation with HCV seropositive donors. F1000Res. 2019; 8.
    View in: PubMed
    Score: 0.495
  2. Disparities in Liver Transplantation Resulting From Variations in Regional Donor Supply and Multiple Listing Practices. Clin Gastroenterol Hepatol. 2017 02; 15(2):313-315.
    View in: PubMed
    Score: 0.394
  3. Trends in Liver Transplantation Multiple Listing Practices Associated With Disparities in Donor Availability: An Endless Pursuit to Implement the Final Rule. Gastroenterology. 2016 09; 151(3):382-386.e2.
    View in: PubMed
    Score: 0.390
  4. Increasing Trends in Transplantation of HCV-Positive Livers Into Uninfected Recipients. Clin Gastroenterol Hepatol. 2019 07; 17(8):1634-1636.
    View in: PubMed
    Score: 0.113
  5. Impact of Drug Overdose Deaths on Solid Organ Transplantation in the United States. J Gen Intern Med. 2018 09; 33(9):1423-1425.
    View in: PubMed
    Score: 0.113
  6. Expanding Donor Pool for Liver Transplantation by Utilizing Hepatitis C Virus-Infected Donors for Uninfected Recipients. Hepatology. 2018 08; 68(2):792-793.
    View in: PubMed
    Score: 0.112
  7. Transplanting hepatitis B surface antigen-positive livers in the United States: Outcomes and opportunities. Am J Transplant. 2023 08; 23(8):1221-1226.
    View in: PubMed
    Score: 0.039
  8. Marginal allografts in liver transplantation have a limited impact on length of stay. Clin Transplant. 2022 03; 36(3):e14544.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.